Accordingly, a Kaplan–Meier analysis conducted after five years of follow-up on 135 CRC patients associated SALL4 expression with a lower survival rate as compared to the SALL4 negative group [161]. This evidence concerns the gene SALL4 and colorectal carcinoma.